Search alternatives:
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
5041
-
5042
-
5043
Transferrin Receptor-Mediated Cellular Uptake of Fluorinated Chlorido[<i>N</i>,<i>N</i>′‑bis(salicylidene)-1,2-phenylenediamine]iron(III) Complexes
Published 2024“…All complexes significantly decreased the metabolic activity in the tested ovarian cancer (A2780, A2780cis), breast cancer (MDA-MB 231), and leukemia (HL-60) cell lines, while the nonmalignant human stroma cell line HS-5 at a concentration of 0.5 μM, which represents the IC<sub>50</sub> of the complexes in most of the used tumorigenic cell lines, was not affected. …”
-
5044
-
5045
-
5046
-
5047
-
5048
-
5049
-
5050
-
5051
-
5052
Reply to Jüni and colleagues regarding “Converting standardized mean differences to dichotomous outcomes: A comment on the Cochrane review ‘Intra-articular corticosteroid for knee...
Published 2019“…Converting standardized mean differences to dichotomous outcomes: A comment on the Cochrane review ‘Intra-articular corticosteroid for knee osteoarthritis’. …”
-
5053
-
5054
-
5055
-
5056
-
5057
Image_5_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf
Published 2019“…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
-
5058
-
5059
-
5060